Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies
Abstract The initial management of rheumatoid arthritis (RA) has a high impact on disease prognosis. Therefore, we need to select the most appropriate treatment as soon as possible. This goal requires biomarkers of disease severity and prognosis. One such biomarker may be the presence of anti-carbam...
Guardado en:
Autores principales: | Cristina Regueiro, Laura Nuño, Ana Triguero-Martinez, Ana M. Ortiz, Alejandro Villalba, María Dolores Bóveda, Ana Martínez-Feito, Carmen Conde, Alejandro Balsa, Isidoro González-Alvaro, Antonio Gonzalez |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b6491be058124b308159c5caeeafb49e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients
por: Cristina Regueiro, et al.
Publicado: (2017) -
Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritis.
por: Jeroen N Stoop, et al.
Publicado: (2014) -
Clinical utility of anti-carbamylated antibody in rheumatoid arthritis female patients: Emerging predictive value compared to anti-cyclic citrullinated peptide and rheumatoid factor
por: Ahmed E. Hafez, et al.
Publicado: (2022) -
Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence
por: Iacono D, et al.
Publicado: (2018) -
The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis
por: Sara Fuentelsaz-Romero, et al.
Publicado: (2021)